Anyone needing digestive support
A review of obesity medications published in JAMA found that: Qsymia was associated with 8% more weight loss than placebo in five randomized controlled trials that included 3,407 participants
Its time to move from reactive treatment to proactive, collaborative prevention
Glucagon receptor activation is thought to increase energy expenditure and promote fat breakdown (lipolysis), which may help explain the substantial weight loss observed in early-phase trials however, these mechanistic effects have not yet been fully characterised in humans and should be regarded as preliminary findings
Weve already sold a staggering 2 million cans in just over a month and a half
Severe or intractable nausea may indicate the need for a slower titration, dose reduction, alternative formulation, or adjunctive medication